vs

Side-by-side financial comparison of FIRST MERCHANTS CORP (FRME) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $157.1M, roughly 1.7× FIRST MERCHANTS CORP). FIRST MERCHANTS CORP runs the higher net margin — 17.9% vs 0.7%, a 17.2% gap on every dollar of revenue.

First Merchants Corporation is a financial holding company in Central Indiana, headquartered in Muncie, Indiana. The Corporation includes First Merchants Bank and First Merchants Private Wealth Advisors. The company is listed on the NASDAQ as FRME. As of March 2023, total asset size of First Merchants Corporation was $18.2 billion. First Merchants offers commercial banking, personal banking, and investment advisor services.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

FRME vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.7× larger
HCM
$270.8M
$157.1M
FRME
Higher net margin
FRME
FRME
17.2% more per $
FRME
17.9%
0.7%
HCM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FRME
FRME
HCM
HCM
Revenue
$157.1M
$270.8M
Net Profit
$28.2M
$2.0M
Gross Margin
37.7%
Operating Margin
-13.2%
Net Margin
17.9%
0.7%
Revenue YoY
-16.5%
Net Profit YoY
-49.1%
-83.6%
EPS (diluted)
$0.45
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRME
FRME
HCM
HCM
Q1 26
$157.1M
Q4 25
$172.2M
$270.8M
Q3 25
$166.1M
Q2 25
$164.3M
$277.7M
Q1 25
$160.3M
$324.5M
Q4 24
$177.1M
Q3 24
$156.0M
Q2 24
$159.9M
$305.7M
Net Profit
FRME
FRME
HCM
HCM
Q1 26
$28.2M
Q4 25
$57.1M
$2.0M
Q3 25
$56.8M
Q2 25
$56.8M
$455.0M
Q1 25
$55.3M
$11.9M
Q4 24
$64.3M
Q3 24
$49.2M
Q2 24
$39.9M
$25.8M
Gross Margin
FRME
FRME
HCM
HCM
Q1 26
Q4 25
37.7%
Q3 25
Q2 25
0.1%
Q1 25
48.0%
Q4 24
Q3 24
Q2 24
41.1%
Operating Margin
FRME
FRME
HCM
HCM
Q1 26
Q4 25
38.0%
-13.2%
Q3 25
39.3%
Q2 25
39.6%
-1.3%
Q1 25
39.4%
-5.0%
Q4 24
43.3%
Q3 24
36.1%
Q2 24
27.5%
-9.0%
Net Margin
FRME
FRME
HCM
HCM
Q1 26
17.9%
Q4 25
33.1%
0.7%
Q3 25
34.2%
Q2 25
34.6%
163.8%
Q1 25
34.5%
3.7%
Q4 24
36.3%
Q3 24
31.5%
Q2 24
25.0%
8.4%
EPS (diluted)
FRME
FRME
HCM
HCM
Q1 26
$0.45
Q4 25
$0.98
$0.00
Q3 25
$0.98
Q2 25
$0.98
$0.52
Q1 25
$0.94
$0.01
Q4 24
$1.09
Q3 24
$0.84
Q2 24
$0.68
$0.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRME
FRME
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$2.7B
$1.2B
Total Assets
$21.1B
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRME
FRME
HCM
HCM
Q1 26
Q4 25
$1.4B
Q3 25
Q2 25
$1.4B
Q1 25
$836.1M
Q4 24
Q3 24
Q2 24
$802.5M
Total Debt
FRME
FRME
HCM
HCM
Q1 26
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
Q3 24
Q2 24
$82.1M
Stockholders' Equity
FRME
FRME
HCM
HCM
Q1 26
$2.7B
Q4 25
$2.5B
$1.2B
Q3 25
$2.4B
Q2 25
$2.3B
$1.2B
Q1 25
$2.3B
$759.9M
Q4 24
$2.3B
Q3 24
$2.3B
Q2 24
$2.2B
$740.1M
Total Assets
FRME
FRME
HCM
HCM
Q1 26
$21.1B
Q4 25
$19.0B
$1.8B
Q3 25
$18.8B
Q2 25
$18.6B
$1.8B
Q1 25
$18.4B
$1.3B
Q4 24
$18.3B
Q3 24
$18.3B
Q2 24
$18.3B
$1.3B
Debt / Equity
FRME
FRME
HCM
HCM
Q1 26
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
Q3 24
Q2 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRME
FRME
HCM
HCM
Operating Cash FlowLast quarter
$8.2M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
1.2%
Capex IntensityCapex / Revenue
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRME
FRME
HCM
HCM
Q1 26
Q4 25
$283.6M
$8.2M
Q3 25
$87.6M
Q2 25
$53.7M
$-72.9M
Q1 25
$61.7M
$40.3M
Q4 24
$266.2M
Q3 24
$76.8M
Q2 24
$63.0M
$-39.8M
Free Cash Flow
FRME
FRME
HCM
HCM
Q1 26
Q4 25
$3.4M
Q3 25
Q2 25
$-82.2M
Q1 25
$32.5M
Q4 24
Q3 24
Q2 24
$-49.9M
FCF Margin
FRME
FRME
HCM
HCM
Q1 26
Q4 25
1.2%
Q3 25
Q2 25
-29.6%
Q1 25
10.0%
Q4 24
Q3 24
Q2 24
-16.3%
Capex Intensity
FRME
FRME
HCM
HCM
Q1 26
Q4 25
1.8%
Q3 25
Q2 25
3.3%
Q1 25
2.4%
Q4 24
Q3 24
Q2 24
3.3%
Cash Conversion
FRME
FRME
HCM
HCM
Q1 26
Q4 25
4.97×
4.21×
Q3 25
1.54×
Q2 25
0.94×
-0.16×
Q1 25
1.11×
3.38×
Q4 24
4.14×
Q3 24
1.56×
Q2 24
1.58×
-1.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRME
FRME

Net Interest Income$151.3M96%
Noninterest Income$5.8M4%

HCM
HCM

Segment breakdown not available.

Related Comparisons